Characteristics of progressive multifocal leukoencephalopathy clarified through internet-assisted laboratory surveillance in Japan

BMC Neurology

Volumn 12, Issue , 2012, Pages

  Nakamichi, Kazuo ^a   Mizusawa, Hidehiro ^b   Yamada, Masahito ^c   Kishida, Shuji ^d   Miura, Yoshiharu ^d   Shimokawa, Toshio ^e   Takasaki, Tomohiko ^a   Lim, Chang Kweng ^a   Kurane, Ichiro ^a   Saijo, Masayuki ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^d TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^e UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Cerebrospinal fluid; Japan; JC virus; Progressive multifocal leukoencephalopathy; Surveillance

Indexed keywords

MONOCLONAL ANTIBODY;

ADULT; ANAMNESIS; ARTICLE; AUTOIMMUNE DISEASE; CEREBROSPINAL FLUID; CHEMOTHERAPY; CLINICAL ARTICLE; DATA BASE; FEMALE; HEMATOLOGIC DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; INTERNET; JAPAN; JC VIRUS; LABORATORY; MALE; MEDICAL INFORMATION; ORGAN DONOR; ORGAN TRANSPLANTATION; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; QUESTIONNAIRE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; STEM CELL TRANSPLANTATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CLINICAL LABORATORY TECHNIQUES; COMORBIDITY; ELECTRONIC HEALTH RECORDS; FEMALE; HEALTH RECORDS, PERSONAL; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; INTERNET; JAPAN; JC VIRUS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MALE; MIDDLE AGED; POLYOMAVIRUS INFECTIONS; POPULATION SURVEILLANCE; PREVALENCE;

EID: 84867374193     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-12-121     Document Type: Article

References (35)

1. Brew BJ, Davies NW, Cinque P, Clifford DB, Nath A. Progressive multifocal leukoencephalopathy and other forms of JC virus disease. Nat Rev Neurol 2010, 6:667-679. 10.1038/nrneurol.2010.164, 21131916.
2. Tan CS, Koralnik IJ. Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis. Lancet Neurol 2010, 9:425-437. 10.1016/S1474-4422(10)70040-5, 2880524, 20298966.
3. Shishido-Hara Y. Progressive multifocal leukoencephalopathy and promyelocytic leukemia nuclear bodies: a review of clinical, neuropathological, and virological aspects of JC virus-induced demyelinating disease. Acta Neuropathol 2010, 120:403-417. 10.1007/s00401-010-0694-x, 2910879, 20464404.
4. Knowles WA, Pipkin P, Andrews N, Vyse A, Minor P, Brown DW, Miller E. Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J Med Virol 2003, 71:115-123. 10.1002/jmv.10450, 12858417.
5. White MK, Khalili K. Pathogenesis of progressive multifocal leukoencephalopathy-revisited. J Infect Dis 2011, 203:578-586. 10.1093/infdis/jiq097, 3072716, 21227915.
6. Garvey L, Winston A, Walsh J, Post F, Porter K, Gazzard B, Fisher M, Leen C, Pillay D, Hill T, Johnson M, Gilson R, Anderson J, Easterbrook P, Bansi L, Orkin C, Ainsworth J, Palfreeman A, Gompels M, Phillips AN, Sabin CA. Antiretroviral therapy CNS penetration and HIV-1-associated CNS disease. Neurology 2011, 76:693-700. 10.1212/WNL.0b013e31820d8b0b, 3053326, 21339496.
7. Garvey L, Winston A, Walsh J, Post F, Porter K, Gazzard B, Fisher M, Leen C, Pillay D, Hill T, Johnson M, Gilson R, Anderson J, Easterbrook P, Bansi L, Orkin C, Ainsworth J, Phillips AN, Sabin CA. HIV-associated central nervous system diseases in the recent combination antiretroviral therapy era. Eur J Neurol 2011, 18:527-534.
8. Choe PG, Park WB, Song JS, Song KH, Jeon JH, Park SW, Kim HB, Chang KH, Oh MD, Choe KW, Kim NJ. Spectrum of intracranial parenchymal lesions in patients with human immunodeficiency virus infection in the Republic of Korea. J Korean Med Sci 2010, 25:1005-1010. 10.3346/jkms.2010.25.7.1005, 2890875, 20592890.
9. Engsig FN, Hansen AB, Omland LH, Kronborg G, Gerstoft J, Laursen AL, Pedersen C, Mogensen CB, Nielsen L, Obel N. Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study. J Infect Dis 2009, 199:77-83. 10.1086/595299, 19007313.
10. Falco V, Olmo M, del Saz SV, Guelar A, Santos JR, Gutierrez M, Colomer D, Deig E, Mateo G, Montero M, Pedrol E, Podzamczer D, Domingo P, Llibre JM. Influence of HAART on the clinical course of HIV-1-infected patients with progressive multifocal leukoencephalopathy: results of an observational multicenter study. J Acquir Immune Defic Syndr 2008, 49:26-31. 10.1097/QAI.0b013e31817bec64, 18667930.
11. Drake AK, Loy CT, Brew BJ, Chen TC, Petoumenos K, Li PC, Wright EJ. Human immunodeficiency virus-associated progressive multifocal leucoencephalopathy: epidemiology and predictive factors for prolonged survival. Eur J Neurol 2007, 14:418-423. 10.1111/j.1468-1331.2007.01686.x, 17388991.
12. Kongsiriwattanakul S, Suankratay C. Central nervous system infections in HIV-infected patients hospitalized at King Chulalongkorn Memorial Hospital. J Med Assoc Thai 2011, 94:551-558.
13. Vidal JE, de Oliveira AC P, Fink MC, Pannuti CS, Trujillo JR. Aids-related progressive multifocal leukoencephalopathy: a retrospective study in a referral center in Sao Paulo, Brazil. Rev Inst Med Trop Sao Paulo 2008, 50:209-212.
14. Lima MA, Bernal-Cano F, Clifford DB, Gandhi RT, Koralnik IJ. Clinical outcome of long-term survivors of progressive multifocal leukoencephalopathy. J Neurol Neurosurg Psychiatry 2010, 81:1288-1291. 10.1136/jnnp.2009.179002, 3077967, 20710013.
15. Khanna N, Elzi L, Mueller NJ, Garzoni C, Cavassini M, Fux CA, Vernazza P, Bernasconi E, Battegay M, Hirsch HH. Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study. Clin Infect Dis 2009, 48:1459-1466. 10.1086/598335, 19348592.
16. Bennett CL. Pharmacovigilance and PML in the oncology setting. Cleve Clin J Med 2011, 78(Suppl 2):S13-S17.
17. Vermersch P, Kappos L, Gold R, Foley JF, Olsson T, Cadavid D, Bozic C, Richman S. Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy. Neurology 2011, 76:1697-1704. 10.1212/WNL.0b013e31821a446b, 21576685.
18. Kothary N, Diak IL, Brinker A, Bezabeh S, Avigan M, Dal Pan G. Progressive multifocal leukoencephalopathy associated with efalizumab use in psoriasis patients. J Am Acad Dermatol 2011, 65:546-551. 10.1016/j.jaad.2010.05.033, 21514689.
19. Holmen C, Piehl F, Hillert J, Fogdell-Hahn A, Lundkvist M, Karlberg E, Nilsson P, Dahle C, Feltelius N, Svenningsson A, Lycke J, Olsson T. A Swedish national post-marketing surveillance study of natalizumab treatment in multiple sclerosis. Mult Scler 2011, 17:708-719. 10.1177/1352458510394701, 21228027.
20. Grinyo J, Charpentier B, Pestana JM, Vanrenterghem Y, Vincenti F, Reyes-Acevedo R, Apanovitch AM, Gujrathi S, Agarwal M, Thomas D, Larsen CP. An integrated safety profile analysis of belatacept in kidney transplant recipients. Transplantation 2010, 90:1521-1527. 10.1097/TP.0b013e3182007b95, 21088650.
21. Piehl F, Holmen C, Hillert J, Olsson T. Swedish natalizumab (Tysabri) multiple sclerosis surveillance study. Neurol Sci 2011, 31(Suppl 3):289-293.
22. Clifford DB, De Luca A, Simpson DM, Arendt G, Giovannoni G, Nath A. Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases. Lancet Neurol 2010, 9:438-446. 10.1016/S1474-4422(10)70028-4, 20298967.
23. Carson KR, Evens AM, Richey EA, Habermann TM, Focosi D, Seymour JF, Laubach J, Bawn SD, Gordon LI, Winter JN, Furman RR, Vose JM, Zelenetz AD, Mamtani R, Raisch DW, Dorshimer GW, Rosen ST, Muro K, Gottardi-Littell NR, Talley RL, Sartor O, Green D, Major EO, Bennett CL. Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the research on adverse drug events and reports project. Blood 2009, 113:4834-4840. 10.1182/blood-2008-10-186999, 2686134, 19264918.
24. Amend KL, Turnbull B, Foskett N, Napalkov P, Kurth T, Seeger J. Incidence of progressive multifocal leukoencephalopathy in patients without HIV. Neurology 2010, 75:1326-1332. 10.1212/WNL.0b013e3181f73600, 20938025.
25. Christensen KL, Holman RC, Hammett TA, Belay ED, Schonberger LB. Progressive multifocal leukoencephalopathy deaths in the USA, 1979-2005. Neuroepidemiology 2010, 35:178-184. 10.1159/000311014, 20664291.
26. Molloy ES, Calabrese LH. Progressive multifocal leukoencephalopathy: a national estimate of frequency in systemic lupus erythematosus and other rheumatic diseases. Arthritis Rheum 2009, 60:3761-3765. 10.1002/art.24966, 19950261.
27. Neff RT, Hurst FP, Falta EM, Bohen EM, Lentine KL, Dharnidharka VR, Agodoa LY, Jindal RM, Yuan CM, Abbott KC. Progressive multifocal leukoencephalopathy and use of mycophenolate mofetil after kidney transplantation. Transplantation 2008, 86:1474-1478. 10.1097/TP.0b013e31818b62c8, 19034021.
28. Nakamichi K, Kurane I, Saijo M. Evaluation of a quantitative real-time PCR assay for the detection of JC polyomavirus DNA in cerebrospinal fluid without nucleic acid extraction. Jpn J Infect Dis 2011, 64:211-216.
29. Howley PM, Rentier-Delrue F, Heilman CA, Law MF, Chowdhury K, Israel MA, Takemoto KK. Cloned human polyomavirus JC DNA can transform human amnion cells. J Virol 1980, 36:878-882. 353715, 6257931.
30. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc 1995, 57:289-300.
31. Koralnik IJ, Schellingerhout D, Frosch MP. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 14-2004. A 66-year-old man with progressive neurologic deficits. N Engl J Med 2004, 350:1882-1893. 10.1056/NEJMcpc030038, 15115835.
32. UNAIDS Global report: UNAIDS report on the global AIDS epidemic 2010 Annex 1 - HIV and AIDs estimates and data, 2009 and 2001, [http://www.unaids.org/documents/20101123_GlobalReport_Annexes1_em.pdf]., UNAIDS.
33. Matsuda T, Marugame T, Kamo K, Katanoda K, Ajiki W, Sobue T. Cancer incidence and incidence rates in Japan in 2006: based on data from 15 population-based cancer registries in the monitoring of cancer incidence in Japan (MCIJ) project. Jpn J Clin Oncol 2012, 42:139-147. 10.1093/jjco/hyr184, 22172347.
34. Egawa H, Tanabe K, Fukushima N, Date H, Sugitani A, Haga H. Current status of organ transplantation in Japan. Am J Transplant 2012, 12:523-530. 10.1111/j.1600-6143.2011.03822.x, 22054061.
35. Aita K. New organ transplant policies in Japan, including the family-oriented priority donation clause. Transplantation 2011, 91:489-491. 10.1097/TP.0b013e318205b3ab, 21248662.